Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
Article in Clinical Lymphoma Myeloma & Leukemia (November 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Clinical Lymphoma Myeloma & Leukemia (November 2023)
Article in Blood Cancer Journal (May 2023)
Article in Journal of Cancer Survivorship (January 2023)